Marc Possover is the pioneer and founder of the neuropelveology - a new branch of medicine that deals with neuropathic pelvic pain, endometriosis of the pelvic nerves and pelvic nerve dysfunctions.

During the past decade, Possover conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Possover" are "Bladder, Overactive" (1 trials) and "Erectile Dysfunction" (1 trials). Many other conditions were trialed in "Possover" in a lesser frequency.

Most popular intervention types in "Possover" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Genital Nerve Stimulation" (1 trials) and "Genital Nerves Stimulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Possover" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Possover". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Possover, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Possover, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".